Antibiotics are critical in the management of a variety of bacterial infections, however, repeated infections produced by relentless bacteria are obstructing effective infection treatment and it is the most significant and vexing problem at the moment. Medicinal chemists face a difficult problem in developing appropriate lead compounds for various diseases, isatin and its hybrids would be one of them due to its versatility in many medications and its derivatives exhibit an extensive variety of structural and mechanistic properties. This review looks at the isatin hybrids that have probable antibacterial action. The structure-activity relationship (SAR) and the way of producing action are also examined in order to locate the course for the intent and expansion of isatin hybrids by means of increased efficacy, reduced toxicity and good pharmacokinetic profiles. Based on the findings, it can be inferred that 3-hydrazone, imine, spiro, oxindole, guanidino and N-alkyl, aryl, acyl substituted isatin hybrids with electronegative groups on other heterocycles have improved bactericidal activity. Furthermore, the antibacterial activity of isatin is dependent on the binding linkage, such as amide (NHCO), carbonyl (CO) or other hetero atom-containing linkers that have improved antibacterial activity. This review gives an idea and scope for the synthesis of novel isatin-containing heterocyclics with the goal of having potent bactericidal activity.
DNA gyrase is a type II topoisomerase enzyme that can cause negative supercoiling in DNA by using the energy produced by ATP hydrolysis. There are two main types of topoisomerases: type I and type II. Type I enzymes cut a single strand of DNA and are further classified as type IA if they connect to a 5′ phosphate of DNA, or type IB if they link to a 3′ phosphate. Type II topoisomerases break both strands, creating a staggered double-strand break. Antimicrobial resistance is a major concern for the global healthcare system. Resistance is the ability of microorganisms to neutralize and withstand antimicrobial drugs previously used to treat microbial infections. Some known classes of DNA gyrase inhibitors are coumarins, cyclothialidines, and quinolones. Antimicrobial medicines such as quinolones have been widely used to treat microbiological diseases. However, the increased use of quinolones has led to the emergence of quinolone-resistant bacteria, which poses a serious risk to public health. Microorganisms can cause resistance due to changes in the target enzymes, DNA gyrase, and topoisomerase IV, which are responsible for transcription and DNA replication. Additionally, differences in drug entry and efflux may also play a role in resistance. Plasmids that produce the Qnr protein can mediate resistance to quinolones by protecting the quinolone targets from inhibition. This review aims to revolutionize the discovery of quinolone-based antibiotics, specifically targeting DNA gyrase, a critical enzyme in bacterial DNA replication, to enhance the efficacy and specificity of anti-microbail agents against microbial infections.
Bacterial resistance poses a significant threat to global healthcare systems and requires innovative solutions to combat this growing problem. In this context, the concept of outer membrane permeability enhancers has emerged as a promising strategy. The gram-negative bacteria's outer membrane acts as a robust defense mechanism, limiting the effectiveness of antibiotics. The introduction of outer membrane permeability enhancers aims to address this challenge by enhancing the permeability of the outer membrane, thus facilitating the entry of antibiotics into bacterial cells. In this chapter, the authors explore the intricacies of outer membrane permeability enhancers like EDTA, polymyxins, aminoglycosides, and tris or tris (hydroxymethyl) aminomethane and their potential impact on bacterial resistance. The outer membrane's composition, comprising lipopolysaccharides, proteins, and phospholipids, creates a formidable barrier that many antibiotics struggle to penetrate.
In targeted drug delivery, antibiotics are precisely delivered to infection areas using nanoparticles and carrier systems, increasing effectiveness, lowering side effects, and causing the least amount of damage to the microbiota. By increasing local antibiotic concentrations, releasing antibiotics selectively depending on bacterial indicators, and using synergistic combination treatments, this approach combats antibacterial resistance. Diagnostics, real-time monitoring, and responsive medication delivery are all combined on multifunctional platforms made possible by nanotechnology. Though problems like biocompatibility and regulatory barriers still exist, recent research has shown promise both in vitro and in vivo. Targeted drug delivery, subject to additional study and invention, offers a method to increase antibiotic effectiveness while tackling resistance. It promises to improve the management of infectious diseases. Targeted distribution can address a variety of problems related to antibacterial resistance.
Benzothiazole and isatin scaffolds possess considerable biological importance and their molecular hybridization may provide a promising approach for enhancing anticonvulsant activity. The present study focused on the design, synthesis and evaluation of a novel series of 6-substituted-N'-(5-substituted-2-oxoindolin-3-ylidene)benzo[d]thiazole-2-carbohydrazide derivatives (IBS01-IBS08) using computational and experimental approaches. Molecular docking studies were performed using AutoDock 1.5.6 against γ-aminobutyric acid (GABA) aminotransferase (PDB ID: 1OHV) to investigate the binding interactions of the synthesized derivatives. The compounds were synthesized and characterized by IR, NMR and mass spectrometry. Their anticonvulsant activity was evaluated in vivo using the maximum electroshock seizure (MES) model at doses of 30 and 100 mg/kg, with hind-limb tonic extension (HLTE) used as the primary endpoint. Phenytoin (25 mg/kg, i.p.) served as the reference standard. The rotarod test was employed to assess motor coordination deficits. The docking results shows the valuable binding interactions of the synthesized hybrids with GABA-aminotransferase. All derivatives markedly decreased the duration of MES-induced HLTE without causing death. Phenytoin demonstrated significant anticonvulsant efficacy (***p < 0.0001) throughout all convulsive phases. The Rotarod test revealed no significant neurotoxic effects at the tested active doses. The synthesized benzothiazole-isatin hybrids exhibited significant anticonvulsant activity, favourable in silico binding affinity and low neurotoxicity, supporting their potential as lead structures for further development of antiepileptic agents.